Early azathioprine/biological therapy is associated with decreased risk for first surgery and delays time to surgery but not reoperation in both smokers and nonsmokers with Crohn's disease, while smoking decreases the risk of colectomy in ulcerative colitis

European Journal of Gastroenterology and Hepatology

Volumn 22, Issue 7, 2010, Pages 872-879

  Szamosi, Tamas ^a,c   Banai, Janos ^a   Lakatos, Laszlo ^b   Czegledi, Zsofia ^a   David, Gyula ^b   Zsigmond, Ferenc ^a   Pandur, Tunde ^b   Erdelyi, Zsuzsanna ^b   Gemela, Orsolya ^c   Papp, Maria ^c,d   Papp, Janos ^c   Lakatos, Peter Laszlo ^c  

^a State Health Centre   (Hungary)

^b SEMMELWEIS UNIVERSITY   (Hungary)

^c Csolnoky F County Hospital   (Hungary)

^d UNIVERSITY OF DEBRECEN   (Hungary)

Author keywords

anti TNF; azathioprine; colectomy; Crohn?s disease; reoperation; resection; risk; smoking; ulcerative colitis

Indexed keywords

ADALIMUMAB; AZATHIOPRINE; INFLIXIMAB; IMMUNOLOGIC FACTOR;

ABDOMINAL PAIN; ADULT; ANUS DISEASE; ARTICLE; BIOLOGICAL THERAPY; CIGARETTE SMOKING; COLON RESECTION; CONTROLLED STUDY; CROHN DISEASE; DISEASE COURSE; DISEASE DURATION; FEMALE; FOLLOW UP; HUMAN; HUNGARY; INTERVIEW; LEUKOPENIA; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; ONSET AGE; PANCREATITIS; PHENOTYPE; PRIORITY JOURNAL; RELAPSE; REOPERATION; RISK ASSESSMENT; RISK REDUCTION; SMOKING HABIT; SURGICAL RISK; THERAPY DELAY; ULCERATIVE COLITIS; ADOLESCENT; COLITIS, ULCERATIVE; MIDDLE AGED; RETROSPECTIVE STUDY; RISK FACTOR; SMOKING; TREATMENT OUTCOME; YOUNG ADULT;

ADOLESCENT; ADULT; AZATHIOPRINE; BIOLOGICAL THERAPY; COLECTOMY; COLITIS, ULCERATIVE; CROHN DISEASE; FEMALE; HUMANS; IMMUNOLOGIC FACTORS; MALE; MIDDLE AGED; REOPERATION; RETROSPECTIVE STUDIES; RISK FACTORS; SMOKING; TREATMENT OUTCOME; YOUNG ADULT;

EID: 77953995887     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: 10.1097/MEG.0b013e32833036d9     Document Type: Article

References (35)

1. Lakatos PL, Fischer S, Lakatos L, Gal I, Papp J. Current concept on the pathogenesis of IBD: crosstalk between genetic and microbial factors. Pathogenic bacteria, altered bacterial sensing or changes in mucosal integrity take toll? World J Gastroenterol 2006; 12:1829-1840.
2. Lakatos PL. Recent trends in the epidemiology of inflammatory bowel diseases: up or down? World J Gastroenterol 2006; 12:6102-6108.
3. Harries AD, Baird A, Rhodes J. Non-smoking: a feature of ulcerative colitis. Br Med J 1982; 284:706.
4. Lindberg E, Jarnerot G, Huitfeldt B. Smoking in Crohn's disease: effect on localisation and clinical course. Gut 1992; 33:779-782.
5. Russel MG, Volovics A, Schoon EJ, vanWijlick EH, Logan RF, Shivananda S, et al. Inflammatory bowel disease: is there any relation between smoking status and disease presentation? European Collaborative IBD Study Group. Inflamm Bowel Dis 1998; 4:182-186.
6. Mahid SS, Minor KS, Stevens PL, Galandiuk S. The role of smoking in Crohn's disease as defined by clinical variables. Dig Dis Sci 2007; 52:2897-2903.
7. Picco MF, Bayless TM. Tobacco consumption and disease duration are associated with fistulizing and stricturing behaviors in the first 8 years of Crohn's disease. Am J Gastroenterol 2003; 98:363-368.
8. Louis E, Michel V, Hugot JP, Reenaers C, Fontaine F, Delforge M, et al. Early development of stricturing or penetrating pattern in Crohn's disease is influenced by disease location, number of flares, and smoking but not by NOD2/CARD15 genotype. Gut 2003; 52:552-557.
9. Cosnes J, Carbonnel F, Carrat F, Beaugerie L, Cattan S, Gendre J. Effects of current and former cigarette smoking on the clinical course of Crohn's disease. Aliment Pharmacol Ther 1999; 13:1403-1411.
10. Sutherland LR, Ramcharan S, Bryant H, Fick G. Effect of cigarette smoking on recurrence of Crohn's disease. Gastroenterology 1990; 98:1123-1128.
11. Reese GE, Nanidis T, Borysiewicz C, Yamamoto T, Orchard T, Tekkis PP. The effect of smoking after surgery for Crohn's disease: a meta-analysis of observational studies. Int J Colorectal Dis 2008; 23:1213-1221.
12. Cottone M, Rosselli M, Orlando A, Oliva L, Puleo A, Cappello M, et al. Smoking habits and recurrence in Crohn's disease. Gastroenterology 1994; 106:643-648.
13. Cosnes J, Nion-Larmurier I, Afchain P, Beaugerie L, Gendre JP. Gender differences in the response of colitis to smoking. Clin Gastroenterol Hepatol 2004; 2:41-48.
14. Cosnes J, Carbonnel F, Beaugerie L, Le Quintrec Y, Gendre JP. Effects of cigarette smoking on the long-term course of Crohn's disease. Gastroenterology 1996; 110:424-431.
15. Aldhous MC, Drummond HE, Anderson N, Smith LA, Arnott ID, Satsangi J. Does cigarette smoking influence the phenotype of Crohn's disease? Analysis using the Montreal classification. Am J Gastroenterol 2007; 102:577-588.
16. Boyko EJ, Koepsell TD, Perera DR, Inui TS. Risk of ulcerative colitis among former and current cigarette smokers. N Eng J Med 1987; 316:707-710.
17. Mokbel M, Carbonnel F, Beaugerie L, Gendre JP, Cosnes J. Effect of smoking on the long-term course of ulcerative colitis. Gastroenterol Clin Biol 1998; 22:858-862.
18. Boyko EJ, Perera DR, Koepsell TD, Keane EM, Inui TS. Effects of cigarette smoking on the clinical course of ulcerative colitis. Scand J Gastroenterol 1988; 23:1147-1152.
19. Fraga XF, Vergara M, Medina C, Casellas F, Bermejo B, Malagelada JR. Effects of smoking on the presentation and clinical course of inflammatory bowel disease. Eur J Gastroenterol 1997; 9:683-687.
20. Hoie O,Wolters F, Riis L, Aamodt G, Solberg C, Bernklev T, et al. Ulcerative colitis: patient characteristics may predict 10-yr disease recurrence in a European-wide population-based cohort. Am J Gastroenterol 2007; 102:1692-1701.
21. Cosnes J. Tobacco and IBD: relevance in the understanding of disease mechanisms and clinical practice. Best Pract Res Clin Gastroenterol 2004; 18:481-496.
22. Hoie O, Wolters FL, Riis L, Bernklev T, Aamodt G, Clofent J, et al. Low colectomy rates in ulcerative colitis in an unselected European cohort followed for 10 years. Gastroenterology 2007; 132:507-515.
23. Aldhous MC, Drummond HE, Anderson N, Baneshi MR, Smith LA, Arnott ID, et al. Smoking habit and load influence age at diagnosis and disease extent in ulcerative colitis. Am J Gastroenterol 2007; 102:589-597.
24. Domenech E, Manosa M, Bernal I, Garcia-Planella E, Cabré E, Piñol M, et al. Impact of azathioprine on the prevention of postoperative Crohn's disease recurrence: results of a prospective, observational, long-term follow-up study. Inflamm Bowel Dis 2008; 14:508-513.
25. D'Haens GR, Vermeire S, Van Asche G, Noman M, Aerden I, Van Olmen G, et al. Therapy of metronidazole with azathioprine to prevent postoperative recurrence of Crohn's disease: a controlled randomized trial. Gastroenterology 2008; 135:1123-1129.
26. Treton X, Bouhnik Y, Mary JY, Colombel JF, Duclos B, Soule JC, et al. Azathioprine withdrawal in patients with Crohn's disease maintained on prolonged remission: a high risk of relapse. Clin Gastroenterol Hepatol 2009; 7:80-85.
27. Markowitz J, Grancher K, Kohn N, Lesser M, Daum F. A multicenter trial of 6-mercaptopurine and prednisone in children with newly diagnosed Crohn's disease. Gastroenterology 2000; 119:895-902.
28. Lennard-Jones JE. Classification of inflammatory bowel disease. Scand J Gastroenterol 1989; 24 (Suppl 170):2-6.
29. Silverberg MS, Satsangi J, Ahmad T, Arnott ID, Bernstein CN, Brant SR, et al. Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a working party of the 2005 Montreal world congress of gastroenterology. Can J Gastroenterol 2005; 19 (Suppl A):5-36.
30. Stange EF, Travis SP, Vermeire S, Beglinger C, Kupcinkas L, Geboes K, et al. European evidence based consensus on the diagnosis and management of Crohn's disease: definitions and diagnosis. Gut 2006; 55 (Suppl 1):i1-i15.
31. Stange EF, Travis SP, Vermeire S, Reinisch W, Geboes K, Barakauskiene A, et al. European evidence-based consensus on the diagnosis and management of ulcerative colitis: definitions and diagnosis. J Crohn's Colitis 2008; 2:1-23.
32. Cosnes J, Beaugerie L, Carbonnel F, Gendre JP. Smoking cessation and the course of Crohn's disease: an intervention study. Gastroenterology 2001; 120:1093-1099.
33. Lémann M, Mary JY, Duclos B,Veyrac M, Dupas JL, Delchier JC, et al. Infliximab plus azathioprine for steroid-dependent Crohn's disease patients: a randomized placebo-controlled trial. Gastroenterology 2006; 130:1054-1061.
34. Seksik P, Nion-Larmurier I, Sokol H, Beaugerie L, Cosnes J. Effects of light smoking consumption on the clinical course of Crohn's disease. Inflamm Bowel Dis 2009; 15:734-741.
35. Van der Heide F, Dijkstra A,Weersma RK, Albersnagel FA, van der Logt EM, Faber KN, et al. Effects of active and passive smoking on disease course of Crohn's disease and ulcerative colitis. Inflamm Bowel Dis 2009; 15:1199-1207.